We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIM icon
201
Kimco Realty
KIM
$15.8B
$669K 0.01%
+26,377
New +$633K
HNST icon
202
The Honest Company
HNST
$638M
$644K 0.01%
175,900
+154,658
+728% +$521K
ETSY icon
203
Etsy
ETSY
$7.02B
$635K 0.01%
+8,430
New +$543K
REED
204
Reed's Inc
REED
$11.3M
$618K 0.01%
486,936
-62,059
-11% -$161K
ARW icon
205
Arrow Electronics
ARW
$11B
$616K 0.01%
+2,885
New +$576K
OLB icon
206
OLB
OLB
$6.27M
$583K 0.01%
+1,531,152
New +$700K
DFSC
207
DEFSEC Technologies
DFSC
$5.03M
$552K 0.01%
+218,000
New +$704K
CAVA icon
208
CAVA Group
CAVA
$7.1B
$548K 0.01%
+6,988
New +$586K
RS icon
209
Reliance Steel & Aluminium
RS
$20.4B
$526K 0.01%
+1,409
New +$515K
AVT icon
210
Avnet
AVT
$7.56B
$522K 0.01%
+5,873
New +$480K
GLNDW
211
Greenland Energy Company Warrant
GLNDW
$3.65M
$510K 0.01%
+600,000
New +$655K
MAC icon
212
Macerich
MAC
$6.59B
$507K 0.01%
+20,112
New +$452K
CALM icon
213
Cal-Maine
CALM
$3.49B
$490K 0.01%
+6,086
New +$470K
ZGN icon
214
Zegna
ZGN
$5.32B
$486K 0.01%
+37,297
New +$481K
DLR icon
215
Digital Realty Trust
DLR
$69.9B
$483K 0.01%
+2,690
New +$515K
QXO
216
QXO Inc
QXO
$13.9B
$479K 0.01%
27,701
+14,157
+105% +$263K
BCTXL
217
BriaCell Therapeutics Warrant
BCTXL
$2.64M
$478K 0.01%
536,600
– –
HWM icon
218
Howmet Aerospace
HWM
$103B
$475K 0.01%
1,767
+682
+63% +$175K
AZO icon
219
AutoZone
AZO
$48.7B
$473K 0.01%
+148
New +$492K
VSEE
220
DELISTED
VSEE HEALTH INC
VSEE
$472K 0.01%
4,079,129
+580,902
+17% +$105K
LOW icon
221
Lowe's Companies
LOW
$115B
$471K 0.01%
2,134
-8,983
-81% -$2.04M
DOW icon
222
Dow Inc
DOW
$21.3B
$466K 0.01%
17,027
+8,325
+96% +$302K
PI icon
223
Impinj
PI
$5.27B
$465K 0.01%
+3,244
New +$423K
FISV
224
Fiserv Inc
FISV
$28.2B
$462K 0.01%
+9,412
New +$526K
SMR icon
225
NuScale Power
SMR
$3.98B
$459K 0.01%
+45,736
New +$516K
7 8
9
10 11

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.